Carregant...
Clinical manufacturing of CAR T cells: foundation of a promising therapy
The treatment of cancer patients with autologous T cells expressing a chimeric antigen receptor (CAR) is one of the most promising adoptive cellular therapy approaches. Reproducible manufacturing of high-quality, clinical-grade CAR-T cell products is a prerequisite for the wide application of this t...
Guardat en:
| Publicat a: | Mol Ther Oncolytics |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4909095/ https://ncbi.nlm.nih.gov/pubmed/27347557 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mto.2016.15 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|